Background The choice of empirical antibiotic treatment for patients with clinically suspected
community-acquired pneumonia (CAP) who are admitted to non–intensive care unit (ICU) …

Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …

Background Left ventricular assist devices (LVADs) are increasingly used for the treatment
of advanced heart failure. LVADs improve quality of life and decrease mortality, but the …

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated
the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-…

OBJECTIVE: To evaluate the potential immunomodulatory effects of statins in community-acquired
pneumonia. METHODS: We performed a systematic review of available literature on …

Background Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and omicron
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…

Background The global push for the use of hydroxychloroquine (HCQ) and chloroquine (CQ)
against COVID-19 has resulted in an ongoing discussion about the effectivity and toxicity of …

Do physicians apply an early-switch strategy (from intravenous to oral antibiotics) in clinically
stable patients hospitalised with community-acquired pneumonia (CAP)? If not, why not? In …

Objectives To test whether Bacillus Calmette-Guérin (BCG) vaccination would reduce the
incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults with one or …

Background Invasive aspergillosis (IA) by a triazole-resistant Aspergillus fumigatus is
associated with high mortality. Real-time resistance detection will result in earlier initiation of …